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Owing to their present use as rocket fuels and their pharmacologic activity as 
central nervous system stimulants, substituted hydrazines and hydrazine derivatives 
have come into increasing use in recent years. The parent compound hydrazine and 
the methyl-substituted hydrazines are of potential hazard because of their toxicity, 
volatility, and explosive nature. Exposure to hydrazine vapor brings about central 
nervous system (CNS) effects resulting in clonic-tonic convulsions and death if the 
exposure is severe; in addition, hydrazine at lower levels of exposure will severely 
damage the liver, resulting in necrosis and fatty infiltration (Comstock et al., 1954). 
Inhalation of l,l-dimethylhydrazine (unsymmetrical dimethylhydrazine, UDMH), 
while producing similar CNS effects, is apparently lacking the severe hepatotoxic 
effects of hydrazine (Rinehart et al., 1960). 
The differences in hepatotoxic action and the exact mechanisms by which these 
compounds exert their CNS effects are not clear, although several recent reports have 
demonstrated that UDMH inhibits glutamic acid decarboxylase and y-aminobutyric- 
a-ketoglutaric transaminase activities in brain tissue. This inhibition can be reversed 
and CNS symptoms alleviated by pyridoxine hydrochloride (Medina et al., 1962; 
Reeves, 1961). 
The present study was undertaken with two objectives in mind: to study the cyto- 
toxic effect of UDMH on tissues and to evaluate several techniques that might be of 
value as sensitive indexes of tissue damage due to UDMH exposure. Serum glutamic- 
oxalacetic transaminase (GOT) was determined since it has been shown to be a rela- 
tively sensitive index of liver damage. Urinary amino acid excretion was measured 
since it may reflect liver or kidney damage or altered protein and amino acid metabo- 
lism. Brain and liver sulfhydryl levels were also studied, as they may be affected by 
the chemical reactivity of UDMH or by its effect on the oxidation-reduction state of 
the tissue. Histopathologic examination of the various tissues was also included in 
this study. 
MATERIALS AND METHODS 
UDMH used in these studies was Eastman Kodak practical grade. For intraperi- 
toneal injection, UDMH was dissolved in 27 mM bicarbonate in 0.9yc saline solution 
(Reeves, 1961). 
All animals were male rats of the Sprague-Dawley strain (Rawley Farms), ap- 
proximately 225-275 g in weight. The animals utilized for enzyme studies and sulf- 
hydryl levels were maintained on an ad libitum diet of Rockland Chow. The rats used 
for amino acid excretion studies were fed a normal protein test diet from Nutritional 
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Biochemical Corporation. These rats were housed in individual metabolism cages 
designed for the collection of urine uncontaminated by feces. Twenty-four-hour urine 
samples were collected, diluted to 20 ml with distilled water, and filtered. Three drops 
of toluene were added to each filtrate and all samples were kept in a refrigerator for 
subsequent paper chromatographic studies. Urinary amino acids were determined in 
triplicate according to the method of Khachadurian et al. (1960). Each rat served as 
its own control, and 24-hour urine samples were collected for a S-day period before 
and after UDMH injection. The urines were analyzed for their creatinine content by 
the Jaffe reaction. The results are also expressed as the ratio of a-amino acid 
nitrogen to creatinine nitrogen. 
Ascending paper chromatography was carried out on 18 X 22-cm sheets of What- 
man no. 1 paper. The solvent systems used were: methanol, n-butanol, benzene, water 
(2: 1: 1: 1) and phenol saturated with buffer (6.3%’ sodium citrate, 3.7% sodium di- 
hydrogen phosphate). For the detection of amino acids, the dried chromatograms were 
sprayed with 0.2’5~ ninhydrin in 95% ethanol. Serum glutamic-oxalacetic transamin- 
ase (GOT) activity was determined by the method of Steinberg et al. (1956). These 
enzyme studies were done on serum samples obtained from rats 18 hours and 5-7 
days after the injection of UDMH. The l&hour time interval was chosen on the 
basis of previous studies which indicate that in acute liver intoxication from CC14 
poisoning, the serum enzyme levels reach a maximum 18-24 hours after administration 
of the toxic compound (Cornish and Block, 1960). The 5-7 day studies were included 
to check for any latent toxicity that might develop. 
Animals to be used for sulfhydryl determinations were stunned by a blow on the 
head and killed by decapitation. Tissues to be analyzed were removed at once, 
weighed, and homogenized immediately with 9 parts of cold 2.5% sulfosalicylic acid 
in an all-glass tissue grinder. Liver samples were cut into small pieces, disintegrated 
with 4-6 strokes, and finally given 20 strokes to complete the process. Brain tissue 
was given 20 strokes to disintegrate the whole organ. The homogenates were centri- 
fuged for 1.5 minutes at 8000 rpm in a cold room. The supernatant fluid was analyzed 
according to the amperometric titration method of Benesch and Benesch (1950). The 
titrations were done in 4.8 M methanol using a supporting electrolyte 1.5 M in 
NH4N03 and 7.5 M in NH40H. One milliliter of standard glutathione (0.001 N), 
2 ml liver homogenate, or 3 ml brain homogenate was added to a mixture of 1 ml 
supporting electrolyte and enough aqueous methanol to give a total of 31 ml. Nitrogen 
was bubbled through this solution for 10 minutes, the rotating platinum electrode 
acting as a stirrer. The titration was carried out with 1 X 10h3 normal AgNOII, using 
a syringe microburette. The end point was determined from a plot of current versus 
milliliters of AgN03 used in the titration. 
Acute Intraperitoneal Toxicity 
RESULTS 
In order to find an appropriate working level where relatively large amounts of 
UDMH could be routinely injected, an acute toxicity study was carried out with the 
following results (Table 1). Eighty milligrams of UDMH per kilogram was the 
maximum intraperitoneal dose which allowed all animals to survive. At 100 mg/kg, 2 of 
4 rats died and at 120 mg/kg, all rats died. The approximate intraperitoneal LD5,, 
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value, calculated on the basis of these preliminary studies, is 100 mg/kg. Mild to 
severe convulsions were evident in the 80-120 mg/kg dose range at the times noted in 
Table 1. 
TABLE 1 
MORTALITY IN RATS FOLLOWING THE INTRAPERITONEAL INJECTION OF UDMH 
Time after 
injection 
(hours) 60 w/kg 
Dosage 
80 m&g 100 mg/kg 120 mg/kg 
l!A NSn O/4 
2 NS O/4 
4 NS O/4 
6 NS O/4 
8 n-s O/4 
Total deaths O/4 
0 NS, no symptoms. 
b SC, severe convulsions. 
C MC, mild convulsions. 
NS O/4 SCb o/4 
MCc O/4 SC o/4 
MC O/4 SC 2,/4 
MC O/4 SC 2/4 








The growth curves of rats given a single intraperitoneal injection of 40, 60, or 80 
mg/kg of UDMH on day 5 are shown in Fig. 1. Only at the 80 mg/kg dose level was 
an actual weight loss noticeable. This occurred only on the day following the injection. 
Food consumption was also decreased by approximately 30% during the 24-hour 
FIG. 1. Growth curves of rats receiving a single intraperitoneal dose of UDMH. 
period following the injection of 80 mg/kg of UDMH. Both food consumption and 
weight gain were normal on subsequent days. 
Serum GOT Levels 
The results of these studies are shown in Table 2. Normal serum GOT levels aver- 
aged 188 * 54 units. No significant changes occurred in serum GOT levels measured 
18 hours and 5-7 days after the injection of UDMH. 
Tissue Sulfhydryl Levels. 
The free sulfhydryl levels in liver and brain of a number of normal rats are pre- 
sented in Table 3. Normal free sulfhydryl levels averaged 217 f 25 mg per 100 g 
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TABLE 2 
SERUM GLUTAMIC OXALACETIC TRANSAMINASE LEVELS IN NORMAL AND UDMH-TREATED RATS 
(80 MG/KG) 
UDMH treated 
Control After 18 hours After 5/7 days 




























a Average k standard deviation. 
TABLE 3 
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a Averages for UDMH-injected rats indicated by boldface figures. 
b Average 2 standard deviation. 
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of liver. These results are quite comparable with several values reported by Benesch 
and Benesch (1950). Normal brain sulfhydryl levels were considerably less than 
liver values and averaged 41 -+ 9 mg per 100 g of brain. The sulfhydryl levels in rat 
tissues after the injection of UDMH are also shown in Table 3. Animals sacrificed 
at 2 hours, 18 hours, and 5-7 days after the injection averaged 222, 187, and 
199 mg’-/- in liver and 40, 43, and 42 rngs respectively in brain. These values are 
not significantly different from control levels. 
Amino Acid Excretion 
The analytical data on amino acid excretion are shown in Table 4. Daily creatinine 
nitrogen values were quite constant within each group of animals and were not affected 
TABLE 4 
CREATININE N AND ~-AMINO ACID N EXCRETION IN RATS INTECTED WITH UDMHa 
Doses Creatinine N a-Amino acid N aAAN: Creatinine N 
(mg/k) Days Control UDMH Control UDMH Control UDMH 
80 1 2.6 2.7 0.360 0.510 0.136 0.187 
2 2.6 2.4 0.300 0.240 0.114 0.100 
3 2.9 2.8 0.274 0.240 0.094 0.085 
4 3.1 3.1 0.353 0.200 0.112 0.065 
5 3.0 3.0 0.300 0.218 0.100 0.074 
60 
40 
1 2.6 2.8 0.310 0.450 0.121 0.163 
2 2.6 2.5 0.246 0.296 0.095 0.119 
3 3.0 2.7 0.242 0.248 0.081 0.092 
4 3.2 3.1 0.320 0.215 0.102 0.070 
5 3.1 3.0 0.307 0.220 0.100 0.076 
1 2.6 3.1 0.360 0.490 0.138 0.158 
2 2.6 2.4 0.284 0.316 0.107 0.131 
3 3.0 3.0 0.240 0.306 0.082 0.104 
4 2.7 3.0 0.344 0.233 0.129 0.078 
5 3.0 3.1 0.353 0.274 0.114 0.088 
0.111 f. 0.011 
0.100 -r- 0.009 
0.114 -r- 0.016 
a Each value in the table is the average obtained on four animals. Standard deviation is shown 
for nitrogen ratio of controls. 
by UDMH injection. a-Amino acid nitrogen excretion, however, showed a marked 
increase during the first 24 hours after the injection of 80, 60, or 40 mg of UDMH 
per kilogram. Since creatinine nitrogen values remain relatively constant for any 
given animal, the a-amino acid nitrogen to creatinine nitrogen ratio represents more 
clearly the change in amino acid excretion over a 24-hour period. At all levels of 
UDMH injection, this ratio is considerably elevated during the first 24 hours after 
UDMH injection. This is followed by a period of decreased amino acid excretion so 
that 5 days after the injection of UDMH the a-amino acid N to creatinine N ratios 
are well below the mean for the control period. A similar group of control animals, 
injected only with the bicarbonate-saline solution, showed no alteration in daily 
amino acid excretion. 
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Paper chromatographic studies of the urinary amino acids did not visually reveal 
any major abnormalities in amino acid distribution. There appears to be an overall 
increase in amino acid excretion which could readily account for the elevations found 
by the analytical procedures. 
Tissue Pathology 
Eight animals were injected with 80 mg of UDMH per kilogram. Four animals were 
sacrificed 1 day, and four animals sacrificed 4 days, after the injection. The tissues 
appeared normal. Histopathologic studies of kidney, pancreas, cerebellum, cerebral 
cortex, choroid plexus, lung, liver, spleen, heart, and pancreas were essentially nega- 
tive and comparable to the control group. 
DISCUSSION 
The approximate acute LDSO of 100 mg/kg found in this study is similar to that of 
104 mg/kg reported by Back and Thomas (1963). Tremors and mild convulsions 
began approximately 2 hours after the injection of 80 mg/kg of UDMH. With doses of 
100 mg/kg, the convulsions began approximately 1% hours after injection and rapidly 
progressed to severe tonic-clonic convulsions. Two of the four animals injected with 
100 mg/kg died in a convulsive state approximately 4 hours after the injection. The 
other two rats convulsed periodically but gradually recovered and survived this dose. 
At a dose level of 120 mg/kg, all four of the injected animals died in a convulsive 
state 4-6 hours after the injection. 
As illustrated in Fig. 1, body weight changes in rats injected with 40, 60, or 80 mg 
UDMH per kilogram were not great. Only the rats injected with 80 mg/kg showed a 
slight loss of weight on the first day after injection with subsequent normal weight 
gains. 
The normal serum GOT levels found in rats injected with relatively large single 
doses of UDMH suggest that liver cell permeability has not been markedly altered 
and that sudden extensive cell death has not occurred in the liver. This is in contrast 
with the findings in CC4 studies where serum GOT levels may be 50 times normal 
levels 24 hours after an acute exposure (Cornish and Block, 1960). Histopathologic 
examination of liver and other tissues 24 hours after the UDMH injection showed no 
tissue pathology. This finding is consistent with the serum enzyme studies. The 
inability to demonstrate direct tissue damage and the normal enzyme levels found in 
these studies would lead one to suggest that the acute toxic effects of UDMH are 
related primarily to its biochemical activity. 
The free sulfhydryl levels in liver and brain of UDMH-treated rats were not signifi- 
cantly different from control levels. Animals sacrificed at 2 hours, 18 hours, and 
5-7 days after UDMH injection maintained normal free sulfhydryl levels in brain 
and liver during this period. Thus it would appear that alterations in the availability 
of free sulfhydryl groups does not contribute to the pharmacologic action of UDMH. 
Free amino acid excretion in urine was definitely increased 24 hours after rats 
were injected with UDMH at the 40, 60, or 80 mg/kg dose level. There appears to 
be a direct correlation of increasing amino acid excretion with increasing dose level 
of UDMH. UDMH when added to 24-hour control urines in amounts equal to the 
entire dose given to a single rat, does not interfere with this calorimetric method 
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for the determination of a-amino acids. The chromatographic studies also indicate 
that there is a rather general increase in overall amino acid excretion, and abnor- 
malities related to specific amino acids are not apparent. Increased amino acid 
excretion, as found in these studies, could result from a number of physiological or 
biochemical disturbances. Tissue damage could release free amino acids into the 
bloodstream. However, the apparent lack of tissue damage histopathologically as 
well as the failure of serum GOT activity to detect liver damage suggests that the 
increased free amino acid excretion may be due to other factors. Massien et al. 
(1962) have recently shown that mice treated with L-glutamic acid-Shydrazide tend 
to accumulate alanine and S-aminobutyric acid in brain, presumably due to the 
inhibition of enzymes involved in amino acid metabolism. Thus it is quite possible 
that UDMH may also interfere with amino acid metabolism not only in brain, but in 
other tissues as well. Interference with protein synthesis or gluconeogenesis could 
also result in the excretion of increased amounts of amino acids. A toxic effect on 
kidney resulting in partial failure to reabsorb amino acids may also be a factor. 
However, with the lack of evidence for structural tissue damage by histopathologic 
methods, it is more likely that the amino acid findings are associated with an effect 
of UDMH upon some more basic physiologic function or biochemical reaction. 
SUMMARY 
The effect of the intraperitoneal injection of UDMH on rat tissue sulfhydryl levels, serum GOT, 
and urinary amino acid excretion has been studied. The approximate LD,, in rats was found 
to be lOOmg/kg. 
Rats given a single injection of 80 mg/kg of UDMH show no changes in liver or brain sulf- 
hydryl levels, nor are serum GOT levels altered by this dose. 
Analyses of urine samples show that rats injected with UDMH at levels of 40, 60, or 80mg/kg 
excrete correspondingly increased amounts of amino acids in the urine during the subsequent 
24-hour period. It appears that this is a general increase in amino acid excretion, and abnor- 
malities associated with specific amino acids are not apparent. 
Histopathologic studies do not reveal any tissue pathology as a result of this single injection of 
UDMH. Since neurologic symptoms are present in these animals, the present findings tend to 
support the evidence for a biochemical mechanism mediating the acute toxic effects of UDMH. 
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